Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Nodular Lymphocyte Predominant Hodgkin Lymphoma
0.060 AlteredExpression disease BEFREE Nineteen of 26 lymph nodes involved by NLPHL demonstrated a population with an LP immunophenotype (73%), which included expression of germinal center markers (CD75/Bcl-6-positive, CD32-weak/negative without CD10), a B-cell immunophenotype (CD19/CD20/CD40<sup>+</sup>), IgD and/or IgM expression (67%), and lack of programmed death-ligand 1/ligand 2. 27998726 2017
Nodular Lymphocyte Predominant Hodgkin Lymphoma
0.060 Biomarker disease BEFREE Altogether, we detected BCL6 abnormalities in 9 of 11 cases of NLPHL (82%). 24678684 2014
Nodular Lymphocyte Predominant Hodgkin Lymphoma
0.060 Biomarker disease BEFREE We report here a case of THRLBCL with a near-tetraploid karyotype and complex chromosomal aberrations, without rearrangement of BCL2 or BCL6, and characterized pathologically by a variegated morphologic appearance with areas resembling nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL). 16856972 2006
Nodular Lymphocyte Predominant Hodgkin Lymphoma
0.060 GeneticVariation disease BEFREE Our results show that translocations juxtaposing the BCL6 oncogene next to the IGH locus are recurrent in NLPHL. 16049307 2005
Nodular Lymphocyte Predominant Hodgkin Lymphoma
0.060 GeneticVariation disease BEFREE The spectrum of BCL6 aberrations targeting IG as well as non-IG loci in NLPHL is similar to that found in DLBCL. 15339680 2004
Nodular Lymphocyte Predominant Hodgkin Lymphoma
0.060 Biomarker disease BEFREE These findings support the hypothesis of a germinal center B cell-derived origin of NLPHL, indicate a significant role of BCL6 in the pathogenesis of NLPHL, and provide further evidence of the genetic diversity underlying the pathogenesis of NLPHL and cHL. 12393409 2003